Early risk assessment of Type 2 Diabetes Mellitus through the use of the biomarker adiponectin
The prevalence of T2DM has reached epidemic levels, affecting about 7% of the U.S. population, and is growing. The Randox automated immunoturbidimetric adiponectin test offers an improved method for assessing T2DM risk, with a convenient format for routine clinical use. The Randox Adiponectin assay is available for use on most biochemistry analysers, including the RX […]